Inventor

BOURRIE BERNARD

FR30 patents

⚠️ This page may combine multiple inventors who share the name “BOURRIE BERNARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOURRIE BERNARD

SANOFI AVENTIS

Use of pyridoindolone derivatives for preparing anticancer medicines

Tetrahydropyridyl-alkyl-heterocycles, method for preparing the same and pharmaceutical compositions containing the same

Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same

Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same

Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof

Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof

Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics

Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics

Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them

Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics

Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents

Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics

Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same

Use of pyridoindolone derivatives for the preparation of medicinal products

Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity

Pyridopyrimidone derivatives, preparation thereof, therapeutic use thereof

Phenyl- and pyridylpiperidines with TNF activity

6-substituted pyridoindolone derivatives, production and therapeutic use thereof

SANOFI SA

Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff&#39;s base and in-vivo prolonged action immunotoxins containing such a glycoprotein

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff&#39;s base and in-vivo prolonged action immunotoxins containing such a glycoprotein

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein

SANOFI SYNTHELABO

Use of central cannabinoid receptor antagonist for preparing medicines

Benzene derivatives, preparation method and pharmaceutical compositions containing same

Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination

Tetrahydropyridines, preparation method and pharmaceutical compositions containing same

SANOFI SYNTELABO

Phenyl- and pyridyl-tetrahydro-pyridines having TNF inhibiting activity

BOURRIE BERNARD

Therapeutic use for treating of leukemia

MUNEAUX YVETTE

6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein

Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein